Esperion Therapeutics, Inc. (ESPR)
2.61
0.00 (0.00%)
USD |
NASDAQ |
Apr 02, 16:00
2.62
+0.01
(+0.38%)
After-Hours: 20:00
Esperion Therapeutics Market Cap : 671.56M for April 2, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Nektar Therapeutics | 1.355B |
| Harrow, Inc. | 1.310B |
| Catalyst Pharmaceuticals, Inc. | 2.997B |
| Regeneron Pharmaceuticals, Inc. | 78.97B |
| Rigel Pharmaceuticals, Inc. | 509.95M |
Market Cap Related Metrics
| PS Ratio | 1.423 |
| Price | 2.61 |
| Earnings Yield | -8.03% |
| Operating PE Ratio | 9.516 |